Nanofiltration Of Factor Vii Solutions To Remove Virus

Patent No. EP1711513 (titled "Nanofiltration Of Factor Vii Solutions To Remove Virus") was filed by Novo Nordisk Health Care on Dec 1, 2004. The application was issued on Jul 2, 2014.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1711513

NOVO NORDISK HEALTH CARE
Application Number
EP04804635A
Filing Date
Dec 1, 2004
Status
Revoked
Oct 12, 2021
Publication Date
Jul 2, 2014